Skip to main content
Top
Published in: Clinical Rheumatology 3/2007

01-03-2007 | Original Article

Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil

Authors: Eutília A. M. Freire, Inês O. Maia, Jamile C. A. Nepomuceno, Rozana M. Ciconelli

Published in: Clinical Rheumatology | Issue 3/2007

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects mainly young women. During the disease course, many organs and systems can suffer non-reversible damage that decreases both the patient’s life span and also their quality of life. To determine the chronic damage and its correlation with quality of life, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index was used in 63 patients who met the ACR criteria for SLE. Quality of life (QOL) was measured through the Medical Outcomes Survey short form 36 (SF-36), sociodemographic data were assessed using specific questionnaires, and disease activity was measured by the systemic lupus erythematosus disease activity index. Overall, 32% of the patients presented damage. Neuropsychiatric (25%) and vascular (20%) involvement were the most frequently related. Organic damages were associated with disease duration (p < 0.03). General health status and social aspects of quality of life were also associated with disease duration (p < 0.05 and p < 0.038, respectively). Socioeconomic status and disease activity were not associated with organic damages and quality of life. This study concluded that disease activity, cumulative damage, and quality of life had some influence in the overall view of lupus but those parameters are distinct domains of health status in SLE. Our analysis identified that disease duration had an important association with damage index and general health status.
Literature
1.
go back to reference Hochberg MC, Dorsch CA, Feinglass EJ, Stevens MB (1981) Survivorship in systemic lupus erythematosus: effect of antibody to extractable nuclear antigen. Arthritis Rheum 24:54–59PubMed Hochberg MC, Dorsch CA, Feinglass EJ, Stevens MB (1981) Survivorship in systemic lupus erythematosus: effect of antibody to extractable nuclear antigen. Arthritis Rheum 24:54–59PubMed
2.
go back to reference Hochberg MC (1984) Systemic lupus erythematosus VIII. Prognosis. Md State Med J 33:114–116PubMed Hochberg MC (1984) Systemic lupus erythematosus VIII. Prognosis. Md State Med J 33:114–116PubMed
3.
go back to reference Hochberg MC (1985) Collagen–vascular disease and disability. In: Hadler NM, Gillings DB (eds) Arthritis and society. Butterworth, London Hochberg MC (1985) Collagen–vascular disease and disability. In: Hadler NM, Gillings DB (eds) Arthritis and society. Butterworth, London
4.
go back to reference Ginzler E, Berg A (1987) Mortality in systemic lupus erythematosus. J Rheumatol 14:218–222 Ginzler E, Berg A (1987) Mortality in systemic lupus erythematosus. J Rheumatol 14:218–222
5.
go back to reference Swaak AJ, Nossent JC, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L, Smeenk RJ (1989) Systemic lupus erythematosus. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:447–454PubMedCrossRef Swaak AJ, Nossent JC, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L, Smeenk RJ (1989) Systemic lupus erythematosus. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:447–454PubMedCrossRef
6.
go back to reference Gladman DD (1992) Prognosis of SLE and factors that affect it. Curr Opin Rheumatol 3:789–796CrossRef Gladman DD (1992) Prognosis of SLE and factors that affect it. Curr Opin Rheumatol 3:789–796CrossRef
7.
go back to reference Gladman D, Urowitz M, Fortin P, Isenberg D, Goldsmith C, Gordon C, Petri M (1996) Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 23:1953–1955PubMed Gladman D, Urowitz M, Fortin P, Isenberg D, Goldsmith C, Gordon C, Petri M (1996) Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 23:1953–1955PubMed
8.
go back to reference Gladman D, Ginzler E, Goldsmith C, Fortin P, Leang M, Urowitz M, Bacon P, Bombardiere S, Hanly J, Hanly J, Hay E, Isenberg D, Imes J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zomia A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369PubMed Gladman D, Ginzler E, Goldsmith C, Fortin P, Leang M, Urowitz M, Bacon P, Bombardiere S, Hanly J, Hanly J, Hay E, Isenberg D, Imes J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zomia A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369PubMed
9.
go back to reference Fallowfield L (1992) An overview of quality of life measurements. In: Trimble MR, Dodson WE (eds) Epilepsy and quality of Life. Raven, New York Fallowfield L (1992) An overview of quality of life measurements. In: Trimble MR, Dodson WE (eds) Epilepsy and quality of Life. Raven, New York
10.
11.
go back to reference Gladman DD, Urowitz M, Ong A, Gough J, Mackinnon A (1996) A comparison of 5 health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 5:190–195PubMed Gladman DD, Urowitz M, Ong A, Gough J, Mackinnon A (1996) A comparison of 5 health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 5:190–195PubMed
12.
go back to reference Stewart AL, Hays RD, Ware JE (1988) The MOS short-form general health survey: reliability and validity in a patient population. Med Care 26:724–735PubMedCrossRef Stewart AL, Hays RD, Ware JE (1988) The MOS short-form general health survey: reliability and validity in a patient population. Med Care 26:724–735PubMedCrossRef
13.
go back to reference Fries JF, Spetz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145PubMed Fries JF, Spetz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145PubMed
14.
go back to reference Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR (1999) Brazilian–Portuguese version of the SF-36. Reliable and valid quality of life outcome measure. Rev Bras Reumatol 39:143–150 Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR (1999) Brazilian–Portuguese version of the SF-36. Reliable and valid quality of life outcome measure. Rev Bras Reumatol 39:143–150
15.
go back to reference Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, Isenberg DA (1997) Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus and a comparison with the MOS SF-20. J Rheumatol 24:1608–1614PubMed Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, Isenberg DA (1997) Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus and a comparison with the MOS SF-20. J Rheumatol 24:1608–1614PubMed
16.
go back to reference Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, Danoff D (1998) Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 7:101–107PubMedCrossRef Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, Danoff D (1998) Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 7:101–107PubMedCrossRef
17.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShanie DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythomatosus. Arthritis Rheum 25:1271–1277PubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShanie DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythomatosus. Arthritis Rheum 25:1271–1277PubMed
18.
go back to reference Bombardier C, Gladman DD, Urowitz M, Caron D, Chang CH (1992) The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35:630–640PubMed Bombardier C, Gladman DD, Urowitz M, Caron D, Chang CH (1992) The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35:630–640PubMed
19.
go back to reference Gladman DD (1994) Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 6:487–492PubMedCrossRef Gladman DD (1994) Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 6:487–492PubMedCrossRef
20.
go back to reference Rivest C, Lew RA, Welseng PM, Sangha O, Wright EA, Roberts WN, Liang MH, Karlson EW (2000) Association between clinical factors, socio-economic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 27:680–684PubMed Rivest C, Lew RA, Welseng PM, Sangha O, Wright EA, Roberts WN, Liang MH, Karlson EW (2000) Association between clinical factors, socio-economic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 27:680–684PubMed
21.
go back to reference Gladman DD, Urowitz M, Ong A, Gough J, MacKinnon A (1996) Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 14:305–308PubMed Gladman DD, Urowitz M, Ong A, Gough J, MacKinnon A (1996) Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 14:305–308PubMed
22.
go back to reference Ferraz LB (2001) Avaliação da qualidade de vida em pacientes com Lupus Eritematoso com manifestações cutâneas. UNIFESP, (Tese) São Paulo Ferraz LB (2001) Avaliação da qualidade de vida em pacientes com Lupus Eritematoso com manifestações cutâneas. UNIFESP, (Tese) São Paulo
23.
go back to reference Meinão I (2001) Utilização de recursos e custos em pacientes com Lupus Eritematoso Sistêmico. UNIFESP, (Tese) São Paulo Meinão I (2001) Utilização de recursos e custos em pacientes com Lupus Eritematoso Sistêmico. UNIFESP, (Tese) São Paulo
24.
go back to reference D’Amorim AB (2001) Avaliação das formas auto-administrativas dos questionários MHAQ e SF-12 em pacientes com doenças reumatológicas. UNIFESP, (Tese) São Paulo D’Amorim AB (2001) Avaliação das formas auto-administrativas dos questionários MHAQ e SF-12 em pacientes com doenças reumatológicas. UNIFESP, (Tese) São Paulo
Metadata
Title
Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil
Authors
Eutília A. M. Freire
Inês O. Maia
Jamile C. A. Nepomuceno
Rozana M. Ciconelli
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0517-6

Other articles of this Issue 3/2007

Clinical Rheumatology 3/2007 Go to the issue

Acknowledgement to Reviewers

Acknowledgement to Reviewers